Project 1: The studies reported in this interval and previously establish the unexpected finding that the development of fibrosis in a chronic inflammation of the gastrointestinal tract is an outgrowth of the inflammation itself, namely the production of Th17 cytokines and the induction of IL-13 synthesis. In addition, they show that fibrosis was ultimately dependent on IL-13 signaling via IL-13Ralpha2 that results in the production of TGF-beta1. The particular focus of the study reported here is the downstream events of the fibrotic program set in motion by the production of TGF-beta1. Evidence is presented that the latter cytokine results in the production of IGF-1 and Egr-1, two factors that mediate old myofibroblast apoptosis and new myofibroblast collagen formation. ? ? Project 2: As pointed out above, """"""""conventional wisdom"""""""" holds that breaches of the epithelial barrier by commensal organisms in the mucosal lumen leads to colitis. In fact, it is widely believed that defects in epithelal barrier function is a cause of Crohn's disease. These studies will require a modification in this view. They provide strong evidence that minor and/or transient breaches of barrier function have, in fact, the opposite effect: the induction of regulatory T cells that prevent colitis. This, in a sense, is not unexpected when it is pointed out that cross-talk between the commensal flora and immune elements in the lamina propria is known to occur even in the absence of disruptions in barrier function. These findings will have important impact on the interpretation of the significance of changes in epithelial barrier function in inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000432-24
Application #
7732455
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
24
Fiscal Year
2008
Total Cost
$794,896
Indirect Cost
City
State
Country
United States
Zip Code
Strober, Warren; Kitani, Atsushi; Fichtner-Feigl, Stefan et al. (2009) The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. Curr Mol Med 9:740-50
Fichtner-Feigl, Stefan; Fuss, Ivan J; Young, Cheryl A et al. (2007) Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 178:5859-70
Boirivant, Monica; Strober, Warren (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23:679-92
Fuss, Ivan J; Becker, Christoph; Yang, Zhiqiong et al. (2006) Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 12:9-15
Strober, Warren; Fuss, Ivan J (2006) Experimental models of mucosal inflammation. Adv Exp Med Biol 579:55-97
Leon, Francisco; Contractor, Nikhat; Fuss, Ivan et al. (2006) Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol 177:6974-82
Oida, Takatoku; Xu, Lili; Weiner, Howard L et al. (2006) TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol 177:2331-9
Fichtner-Feigl, Stefan; Strober, Warren; Kawakami, Koji et al. (2006) IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12:99-106
Strober, Warren (2006) Immunology. Unraveling gut inflammation. Science 313:1052-4
Di Giacinto, Claudia; Marinaro, Mariarosaria; Sanchez, Massimo et al. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:3237-46

Showing the most recent 10 out of 22 publications